Open house Drug Discount Agreements Trastuzumab, ATC L01FD01
Open house Arzneimittelrabattverträge Trastuzumab, ATC L01FD01
Germany · München · how to bid here →
Your path to submission
- Deadline: 5 October at 12:00 — 1 day left.
- You submit on Vergabemarktplatz (cosinex) — not here and not by e-mail. ↗ Free bidder account on the cosinex platform required (created instantly); offers go through the bidding tool, usually plain text form suffices — no qualified signature. Sort out account and signature first — not on submission day.
- Offer and evidence in: DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every month (810 awards, most recently September 2026) — the next award is due around November 2026 by that rhythm. The last award went to Ipsen Pharma GmbH.n = 810
- 72% of this buyer's awards went to companies that had already won here before (1,127 awards since 2017, spread over 321 companies). 28% went to new names.n = 1,127 awards since 2017
- The median procedure drew just one bid (1,070 procedures with a bid count); 78% ended with a single bidder. Sector: median 2 bids.n = 1,070
- 66% of the bids received came from small and medium-sized enterprises (16 procedures with a bid mix). Sector: 38%.n = 16
- The award came in at a median 98% of the estimated value (5 awards with both estimate and value) — pricing at the estimate is usually about right here. Sector: 87%.n = 5
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,111 recorded awards) — mostly from Austria, Netherlands, France.
Typical field: median 1 (from 1,211 awards).
What the buyer is looking for
It is not an open procedure, but an open-house model! The open procedure form is only used because there is no form for the open house model. Contracts concluded in the open-house model are not subject to public procurement law due to the absence of a selection decision. Submission to procurement regulations is not associated with the use of this form. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies on the active substance trastuzumab, ATC L01FD01, in accordance with § 130a(8) SGB V. AOK Bayern offers all interested pharmaceutical companies that meet the eligibility requirements listed below the conclusion of identical and non-individually negotiable discount agreements. The earliest possible start date is 01.12.2024, all contracts end on 30.11.2026. Conclusion of a contract is possible at any time during this term, but at the latest on 05.10.2026. Contracts may be terminated with a notice period of one month to the end of the month.
What you must prove — eligibility criteria
From the notice of the same procedure on TED — Tenders Electronic Daily.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| ratiopharm GmbH | 56 | 2014–2023 |
| Hexal AG · Holzkirchen | 46 | 2011–2022 |
| Aliud Pharma GmbH · Laichingen | 45 | 2011–2023 |
| Haemato Pharm GmbH · Schönefeld | 43 | 2014–2022 |
| Orifarm GmbH · Leverkusen | 39 | 2018–2023 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.
How to bid
Guide: how to apply on cosinex Vergabemarktplatz / DTVP → Registration, signature, fees — from the operator's bidder manual.